Russia’s diabetes market is set be worth $1.7 billion by 2015, according to a new report. Industry analysts Decision Resources’ …
Teva has joined a number of its peers in the pharmaceutical sector and announced plans to build a new manufacturing …
Quintiles is set to launch its first contract sales project in Russia with a 40 strong sales team. The company …
Novartis has started construction of its new pharmaceutical manufacturing plant in St. Petersburg, Russia.The company has broken ground on the …

AstraZeneca is moving further into Russia with the establishment in St. Petersburg of a facility which aims to better assess …
AstraZeneca has become the latest drugmaker to announce the construction of a manufacturing facility in Russia to help sidestep possible …
Novartis is planning to invest $500 million in Russia over the next five years, in a programme which will include …
Russian active pharmaceutical ingredient manufacturer Pharmsynthez is planning a listing on the MICEX stock exchange to help it expand beyond …

The US is not the only country in the throes of passing significant legislation on major health issues.A bill has …

Ask almost any pharmaceutical marketer where the future growth lies for the industry, and the answer will be almost certainly …

Russia endured a turbulent 2009 in economic terms, thanks to the steep drop in oil prices, but the country is …
Swiss drugmaker Nycomed has provided more details of its plan to build a large-scale production facility in Russia.In July, Nycomed …
Swiss pharmaceutical company Nycomed is already a big player in the Russian drug market, and looks set to consolidate that …